Phase Out in Tinnitus Patients
Phase Out Treatment for Tinnitus
1 other identifier
interventional
40
1 country
1
Brief Summary
Phase shift treatment is a new tinnitus therapy that aims at sound cancelling via complete or partial residual inhibition. This technique is based on the theory by Choy advocating that the induction of a sound wave with a 180 degree phase shift compared to the sound experienced by the patient could result in sound cancelling, likely by negation of the cortical perception of tinnitus. The aim is to determine the efficacy of the Phase Out treatment in pure tone and narrow band noise tinnitus patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 30, 2009
CompletedFirst Posted
Study publicly available on registry
February 2, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2009
CompletedMarch 3, 2009
December 1, 2008
1 year
January 30, 2009
March 2, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual Analogue Scale
3x/week
Secondary Outcomes (1)
Score on Tinnitus Questionnaire
week 0, week 3, week 6
Study Arms (1)
narrow band noise
EXPERIMENTALPhase out in narrow band noise tinnitus patients
Interventions
Phase Out treatment: 30 min 3x/w during 6 weeks
Eligibility Criteria
You may qualify if:
- consult ENT department UZA with tinnitus
- pure tone tinnitus or narrow band noise tinnitus
- unilateral tinnitus, or bilateral tinnitus if both ears pure tone or both ears narrow band noise
- frequency tinnitus \> 1kHz
- cochlear origin tinnitus
- tinnitus duration 3 months or longer
- age 18y or more
- patient being able to cooperate
- patiënt able to fill in VAS
- normal MRI pontine angle
You may not qualify if:
- depression: BDI \> 21
- pulsatile tinnitus
- pregnancy
- epilepsy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antwerp university Hospital
Edegem, Antwerp, 2650, Belgium
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 30, 2009
First Posted
February 2, 2009
Study Start
March 1, 2008
Primary Completion
March 1, 2009
Last Updated
March 3, 2009
Record last verified: 2008-12